Endo and BioDelivery Sciences submit NDA for transmucosal pain med
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 11:41AM CST
MNK: 97.84 (-0.29), BDSI: 12.65 (+0.66), ENDP: 72.10 (+0.34), EGLT: 5.97 (+0.21), ZGNX: 1.20 (+0.04), PFE: 31.42 (-0.03), TEVA: 57.09 (+0.33), ABBV: 66.21 (+1.86), ALKS: 56.16 (+1.02), ACUR: 0.52 (+0.02)
Biotech Stocks Take A Beating, But Find Support
at Investor's Business Daily - Wed Dec 24, 5:24PM CST
Biotech stocks took a bath in this holiday-shortened week. The catalyst was the announcement by Express Scripts (ESRX), the nation's largest benefits manager, to use AbbVie's (ABBV) hepatitis C drug exclusively. That hurt Gilead Sciences (GILD),...
CBPO: 64.79 (-0.59), ODFL: 79.34 (+0.71), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), AMGN: 160.67 (+3.15), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)
Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)
Stocks Score Small Gains; Virgin America Takes Flight
at Investor's Business Daily - Wed Dec 24, 10:57AM CST
Stocks were filled with Christmas cheer with a little more than one hour remaining in Wednesday's shortened session. The Dow Jones industrial average and the S&P 500 were trading at all-time highs. The Nasdaq led the charge, up 0.4%. The S&P 500 and...
ESRX: 85.48 (-0.40), V: 267.63 (+2.37), VA: 41.00 (+5.19), GILD: 91.29 (+1.84), BAC: 17.98 (+0.05), SN: 9.91 (-0.71), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 24, 8:48AM CST
Will Express Scripts' announcement regarding AbbVie's (ABBV) Viekira Pak lead to a pricing war in the hepatitis C virus (HCV) market?
BIIB: 340.89 (+5.13), VRTX: 115.15 (+1.40), CBST: 100.29 (-0.09), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), IMGN: 5.90 (+0.13), ABBV: 66.21 (+1.86)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), FBT: 100.93 (+1.47), BIB: 122.51 (+3.83), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)
The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 8:03AM CST
For shareholders of Gilead Sciences it's practically been a dream year . Shares rose close to 40%, tacking on roughly $45 billion in market value, following the successful approval and launch of oral hepatitis C drugs Sovaldi and Harvoni. ...
JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01), ENTA: 49.04 (+0.06)
Gilead Feels The Heat Of Competition
Brendan O'Boyle - at Seeking Alpha - Wed Dec 24, 6:59AM CST
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:50PM CST
Pharmacy benefit manager Express Scripts (ESRX) announced an update to its National Preferred Formulary, which will now include AbbVie's (ABBV) recently approved new medication for hepatitis C, Viekira Pak.
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), CRL: 63.59 (+0.33)
AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
Kal Telage - at Seeking Alpha - Tue Dec 23, 3:41PM CST
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Dow Reaches Record Close as Santa Claus Rally Hits Day 5
at The Street - Tue Dec 23, 3:04PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
PSX: 72.10 (-0.46), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), XOM: 93.78 (-0.81), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), CVX: 113.47 (-0.48), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07), XLE: 80.13 (-0.59)
Why Achillion Pharmaceuticals Shares Collapsed by 25% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 2:03PM CST
Source: Achillion Pharmaceuticals What's happening? Shares of Achillion Pharmaceuticals are crashing 25% today after the company reported mixed early stage drug trial results yesterday and following Express Scripts ' decision to remove ...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86)
Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 303.03 (-3.26), IBB: 299.80 (+5.12), ALSN: 33.94 (+0.05), BAC: 17.98 (+0.05), TLT: 123.95 (+0.41), GOOG: 528.77 (-1.82), ESRX: 85.48 (-0.40), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), GILD: 91.29 (+1.84), DIA: 180.03 (unch), APA: 64.05 (-1.38), ABBV: 66.21 (+1.86), BP: 38.95 (-0.17), GOOGL: 536.93 (-1.84), IWM: 119.76 (-0.10), XLE: 80.13 (-0.59)
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
at The Street - Tue Dec 23, 1:25PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
GPRO: 66.41 (+4.87), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying
at The Street - Tue Dec 23, 12:48PM CST
The biotech stock's shares fell again Tuesday following the news of Express Scripts' exclusive deal with AbbVie. Here's what analysts said about Gilead.
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Biotech Stocks Are Falling: 3 Top Stocks to Buy
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 12:41PM CST
Source: Celgene Corp. Biotechnology stocks have been one of the market's darlings over the past year. The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has roughly doubled the S&P 500's return over the past 5 weeks. Today though, the ETF is...
BIIB: 340.89 (+5.13), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)
Toys, Department Stores Rock, But Biotechs Tumble
at Investor's Business Daily - Tue Dec 23, 11:06AM CST
The euphoria over third-quarter GDP growth of 5% evaporated Tuesday morning, leaving stocks trading mixed at midday, with the Nasdaq leading other indexes off their best levels. The Nasdaq was off 0.1% ,the S&P 500 rose 0.3% and the Dow Jones...
HAS: 55.25 (+0.03), BIIB: 340.89 (+5.13), PCYC: 121.84 (+1.15), M: 64.26 (+0.22), CELG: 109.60 (+3.48), DDS: 122.53 (+0.53), ESRX: 85.48 (-0.40), MAT: 30.22 (-0.16), GILD: 91.29 (+1.84), JCP: 6.50 (-0.24), ALXN: 181.96 (+3.09), ABBV: 66.21 (+1.86)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 49.81 (+0.69), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower
at The Street - Tue Dec 23, 10:29AM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as stock markets gain.
AVP: 9.22 (-0.07), GMCR: 137.65 (+1.10), NQ: 4.32 (-0.36), SBUX: 81.27 (-0.16), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)